Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 21, 2006; 12(11): 1747-1751
Published online Mar 21, 2006. doi: 10.3748/wjg.v12.i11.1747
Published online Mar 21, 2006. doi: 10.3748/wjg.v12.i11.1747
Table 1 Subject characteristics and plasma glucose, insulin, and lipid levels
Parameter | Control group | Non-obese diabetes group | Obese diabetes group |
n | 28 | 30 | 30 |
Age (yr) | 47 ± 11 | 48 ± 8 | 52 ± 9 |
Gender (M/F) | 14/14 | 14/16 | 16/14 |
BMI (kg/m2) | 24.03 ± 4.05 | 23.13 ± 1.62 | 27.25 ± 1.71ac |
FPG (mmol/L) | 4.97 ± 0.56 | 9.9 ± 2.03a | 10.03 ± 2.08a |
FINS (mU/L) | 6.25 ± 4.22 | 9.52 ± 7.81 | 8.72 ± 4.64 |
IR | 0.50 ± 0.35 | 0.98 ± 0.59a | 1.22 ± 0.53a |
ISI | -3.61 ± 0.35 | -4.09 ± 0.59a | -4.33 ± 0.54a |
TCH (mmol/L) | 4.79 ± 1.07 | 5.79 ± 1.42a | 5.61 ± 1.79a |
TG (mmol/L) | 1.48 ± 1.74 | 2.45 ± 1.46a | 3.05 ± 1.92a |
NEFA (mmol/L) | 0.71 ± 0.18 | 0.95 ± 0.21a | 1.13 ± 0.24a |
- Citation: Lu HL, Wang HW, Wen Y, Zhang MX, Lin HH. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes. World J Gastroenterol 2006; 12(11): 1747-1751
- URL: https://www.wjgnet.com/1007-9327/full/v12/i11/1747.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i11.1747